MA34946B1 - Nouvelles benzodioxolepipérazines - Google Patents

Nouvelles benzodioxolepipérazines

Info

Publication number
MA34946B1
MA34946B1 MA36210A MA36210A MA34946B1 MA 34946 B1 MA34946 B1 MA 34946B1 MA 36210 A MA36210 A MA 36210A MA 36210 A MA36210 A MA 36210A MA 34946 B1 MA34946 B1 MA 34946B1
Authority
MA
Morocco
Prior art keywords
benzodioxolepiperazines
new
formula
present
ht2a
Prior art date
Application number
MA36210A
Other languages
English (en)
Inventor
Sarmiento Rosa Maria Rodriguez
Juergen Wichmann
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MA34946B1 publication Critical patent/MA34946B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

LA PRÉSENTE INVENTION CONCERNE DE NOUVEAUX MODULATEURS DOUBLES DES RÉCEPTEURS 5-HT2A ET D3 DE FORMULE (I) OÙ N, Y, R1, R2, R3 ET R4 SONT TELS QUE DÉCRITS DANS LA PRÉSENTE INVENTION, AINSI QUE LEURS SELS ET ESTERS DE QUALITÉ PHARMACEUTIQUE. EN OUTRE, LA PRÉSENTE INVENTION CONCERNE LA FABRICATION DES COMPOSÉS DE FORMULE (I), LES COMPOSITIONS PHARMACEUTIQUES LES INCLUANT ET LEUR UTILISATION COMME MÉDICAMENTS.
MA36210A 2011-02-17 2012-02-14 Nouvelles benzodioxolepipérazines MA34946B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11154780 2011-02-17
PCT/EP2012/052440 WO2012110470A1 (fr) 2011-02-17 2012-02-14 Nouvelles benzodioxolepipérazines

Publications (1)

Publication Number Publication Date
MA34946B1 true MA34946B1 (fr) 2014-03-01

Family

ID=45722618

Family Applications (1)

Application Number Title Priority Date Filing Date
MA36210A MA34946B1 (fr) 2011-02-17 2012-02-14 Nouvelles benzodioxolepipérazines

Country Status (19)

Country Link
US (1) US8722683B2 (fr)
EP (1) EP2675798B1 (fr)
JP (1) JP2014505715A (fr)
KR (1) KR20140006953A (fr)
CN (1) CN103380122B (fr)
AR (1) AR085236A1 (fr)
AU (1) AU2012217150A1 (fr)
BR (1) BR112013020656A2 (fr)
CA (1) CA2823988A1 (fr)
CO (1) CO6761304A2 (fr)
CR (1) CR20130318A (fr)
EA (1) EA201391124A1 (fr)
EC (1) ECSP13012838A (fr)
ES (1) ES2546430T3 (fr)
HK (1) HK1189880A1 (fr)
MA (1) MA34946B1 (fr)
MX (1) MX2013008531A (fr)
SG (1) SG192819A1 (fr)
WO (1) WO2012110470A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106518841B (zh) * 2015-09-15 2019-03-05 浙江京新药业股份有限公司 环己烷衍生物或其立体异构体或盐及其制备与应用
EP3495363B1 (fr) 2016-07-28 2023-08-23 Shionogi & Co., Ltd Composés cycliques condensés contenant de l'azote ayant un effet antagoniste du récepteur de la dopamine d3
CN111801330B (zh) 2018-01-26 2024-04-05 盐野义制药株式会社 具有多巴胺d3受体拮抗作用的稠环化合物
WO2019146740A1 (fr) 2018-01-26 2019-08-01 塩野義製薬株式会社 Composé cyclique présentant un antagonisme au récepteur d3 de la dopamine
CN111770754B (zh) * 2019-01-30 2023-09-19 江苏豪森药业集团有限公司 一种多环类衍生物调节剂、其制备方法和应用
CN110372557B (zh) * 2019-08-06 2021-05-18 上海勋和医药科技有限公司 环己烷胺类d3/d2受体部分激动剂

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3347381B2 (ja) * 1993-01-27 2002-11-20 協和醗酵工業株式会社 ペットフード
WO1996039133A1 (fr) 1995-06-06 1996-12-12 Neurobiological Technologies, Inc. Nouvelles 2-amino-3'-4'-methylene-dioxypropiophenones n-substituees
EP1683790A1 (fr) * 2005-01-24 2006-07-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) Dérivés de 3,4-dihydro-2-naphtamide comme ligands selectifs de la dopamine D3
HUP0500170A3 (en) * 2005-02-03 2007-11-28 Richter Gedeon Nyrt Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
BRPI0707960A2 (pt) 2006-02-17 2011-05-10 Hoffmann La Roche derivados de benzoil-piperidina como moduladores de 5ht2/d3, medicamento e uso dos mesmos
AU2007316249B2 (en) * 2006-10-31 2013-01-24 F. Hoffmann-La Roche Ag Ether derivatives dual modulators of the 5-HT2A and D3 receptors
AU2008280187B2 (en) * 2007-07-26 2013-05-16 F. Hoffmann-La Roche Ag Dual modulators of 5-HT2A and D3 receptors
US7875610B2 (en) * 2007-12-03 2011-01-25 Richter Gedeon Nyrt. Pyrimidinyl-piperazines useful as D3/D2 receptor ligands
AU2009294695B2 (en) * 2008-09-22 2012-09-13 F. Hoffmann-La Roche Ag Piperazine D3 and 5-HT2a receptor modulators
WO2010034648A1 (fr) * 2008-09-23 2010-04-01 F. Hoffmann-La Roche Ag Dérivés de pyridinylpipérazine utiles en tant que modulateurs de récepteurs d3 de la dopamine
US8586579B2 (en) * 2010-06-21 2013-11-19 Hoffmann-La Roche Inc. Anellated pyridine compounds
US8598357B2 (en) * 2011-03-03 2013-12-03 Hoffmann-La Roche Inc. Benzodioxole piperidine compounds

Also Published As

Publication number Publication date
EP2675798A1 (fr) 2013-12-25
CO6761304A2 (es) 2013-09-30
HK1189880A1 (en) 2014-06-20
KR20140006953A (ko) 2014-01-16
BR112013020656A2 (pt) 2016-10-18
JP2014505715A (ja) 2014-03-06
US8722683B2 (en) 2014-05-13
CA2823988A1 (fr) 2012-08-23
AU2012217150A1 (en) 2013-05-02
EA201391124A1 (ru) 2014-02-28
ECSP13012838A (es) 2013-09-30
AR085236A1 (es) 2013-09-18
EP2675798B1 (fr) 2015-07-01
CN103380122A (zh) 2013-10-30
CN103380122B (zh) 2015-04-29
MX2013008531A (es) 2013-08-12
SG192819A1 (en) 2013-09-30
US20130040948A1 (en) 2013-02-14
WO2012110470A1 (fr) 2012-08-23
ES2546430T3 (es) 2015-09-23
CR20130318A (es) 2013-09-03

Similar Documents

Publication Publication Date Title
MA33939B1 (fr) 5-alcynyl-pyrimidines
MA37886A1 (fr) Nouvelles pyridinones bicycliques
MA34069B1 (fr) Dérivés de n-(imidazopyrimidin-7-yl)hétéroarylamide et leur utilisation comme inhibiteurs de pde10a)
EA201171066A1 (ru) Новые замещенные производные бензоксазола, бензимидазола, оксазолопиридина и имидазопиридина в качестве модуляторов гамма-секретазы
MA37400B1 (fr) Composés hétérocyclyle en tant qu'inhibiteurs de mek
TN2012000543A1 (en) Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
EA201290654A1 (ru) Новые замещенные триазольные производные как модуляторы гамма-секретазы
UA111770C2 (uk) Інгібітори бромдомену
BR112014000713A2 (pt) derivados de indol substituído como moduladores de gama secretase
EA201001205A1 (ru) Соединения, содержащие циклобутоксигруппу
MA34946B1 (fr) Nouvelles benzodioxolepipérazines
CO6460772A2 (es) Inhibidores de la replicación del virus de la inmunodeficiencia humana
EA201170772A1 (ru) Органические соединения
UY32259A (es) Nuevos compuestos de hidroxiareno, preparados farmaceuticos que los contienen y aplicaciones
EA201792046A1 (ru) Модуляторы рецептора андрогенов и их применение
MA35749B1 (fr) Dérivés nucléosidiques 4'-azido, 3'-fluoro substitués en tant qu'inhibiteurs de la réplication de l'arn du vhc
EA201270216A1 (ru) Фармацевтический состав
EA201490471A1 (ru) Пиридазиноновые соединения и их применение в качестве ингибиторов daao
EA201201050A1 (ru) Пиразолы в качестве антагонистов crth2
EA201491002A1 (ru) Производные [1,2,3]триазоло[4,5-d]пиримидина в качестве агонистов каннабиноидного рецептора 2
CR20130239A (es) Compuestos de triazolopiridina
EA201190320A1 (ru) Гетероциклические сульфонамиды, их применения и фармацевтические композиции
MA33948B1 (fr) Dérivés d'acide 3-hétéroaroylamino-propionique substitues par oxygène et leur utilisation en tant qu'agents pharmaceutiques.
EA201001855A1 (ru) Соединения, содержащие циклобутоксигруппу
EA201290229A1 (ru) Производные спиролактама и их применение